Almira Bartolome

Almira Bartolome

Executive Director, Commercial Development, Advanced Therapies and Vaccines

FUJIFILM Diosynth Biotechnologies

About me

Former Scientist and Business Development Professional with more than 12 years working in the Advanced Therapies Space. Currently leading the European Commercial team at FUJIFILM Diosynth Biotechnologies, where we support gene and cell therapy development and manufacturing needs across our global network.
Exhibitor Access Type
Exhibitor - In person & Online
Country
Denmark
Markets Active In
Europe - EU countries
Geographical areas your company plans to expand into
AfricaEurope - EU countries

About me (Individual)

Department
Sales
Job Function
Director, Commercial Development-EuropeVP/Director
Purchasing Responsibility
I have no purchasing responsibility

Offering/Interested In

Interested in: Department
General ManagementInvestmentPurchasing/ Procurement/ SourcingResearch & Development
Interested in: Company Type
Academic/ResearchAssociation/GovernmentConsultancyManufacturer/Innovator
Interested In: Company Certification
None
Interested In: Product Certification
None

Interested In

Interested In: Products & Service Category
Biopharmaceuticals
Interested In: Biopharmaceuticals
Academia and Research CentresAntibody Drug Conjugates (ADCs)Antisense, RNABio ClustersBiomanufacturingBiopharmaceuticals (general category)BiosimilarsCell & Gene therapyCHO and cell linesCMCMonoclonal AntibodiesPlatform TechnologiesRegenerative Medicine

Social media

Is member of

Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies
Exhibitors

is attending

Biologics Capability and Capacity Expansion Driving Shift to CRDMO Business Models

Tuesday, October 24, 2023 10:05 AM to 10:25 AM
CPHI Content Hub - CC4.3

Process Optimization for Viral Vector Manufacturing

Tuesday, October 24, 2023 10:30 AM to 10:50 AM
CPHI Content Hub - CC4.3

CDMO 2.0: Uncovering the Missing Element in Next-Generation Pharma Partnerships

Tuesday, October 24, 2023 12:15 PM to 12:35 PM
CPHI Content Hub - CC4.3
Peter Andersen · Grupo Centroflora

CDMO Selection for the Biotech: A Practical Guide

Tuesday, October 24, 2023 12:40 PM to 1:00 PM
CPHI Content Hub - CC4.3

State of the Industry: Global Trends and Future Opportunities for Cell and Gene Therapies

BioProduction Content - 3C49

Log in

See all the content and easy-to-use features by logging in or registering!